Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03328104
Title Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Emory University
Indications

peripheral T-cell lymphoma

T-cell acute lymphoblastic leukemia

lymphoblastic lymphoma

Therapies

Cyclophosphamide + Etoposide + Everolimus + Nelarabine

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.